• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
april@madhedgefundtrader.com

The New Hot A.I. Stock

Tech Letter

Super Micro Computers (SMCI) could be a legitimate dark horse in this race to AI supremacy.

They are the meat of the whole operation.

This is an upstart company from California who really knows their stuff about computer infrastructure.

Although they are no Nvidia, they do pack a punch and its share price has exploded higher as the company has been buoyed by both excellent quarterly results and an even better forecast for the full year.

Institutional interest is also gaining steam as the stock continues to be bid up to higher highs.

It’s proving itself, along with Nvidia, to be one of the cleanest stock plays on the AI theme.

Shares of SMCI were languishing lower than $20 per share in 2019.

Fast forward to today and underlying shares are sitting pretty at $750 per share.

Nvidia and Supermicro are somewhat correlated.

Nvidia’s high-performance chips are essential for the AI revolution, they need cutting-edge data infrastructure and that’s how Supermicro’s slots in nicely.

SMCI takes an innovative, customized, and flexible approach to meet customers’ computing needs – which has made it the choice of heavyweight clients like Meta and Amazon. SMCI supplies in rapid time, and the uber-complicated tech behind these centers, which needs servers, networks, and cloud storage solutions to function.

The company also uses a liquid cooling technique to manage the temperature of its multi-rack servers in a more energy-efficient way.

By the end of September, research firm IDC estimated that Supermicro had become the fourth-biggest server provider in the world, ahead of Lenovo.

And, sure, Dell and Hewlett Packard Enterprise are the leaders, but their revenue growth has been falling while Supermicro’s is muscling up at a double-digit pace, making it a leader in the higher-priced and higher-margin AI server market.

In its latest earnings report, SMCI announced revenues of $3.66 billion, a 133% increase from the year-earlier period, and predicted sales of at least $14.3 billion in 2024.

Supermicro’s leadership will not stay inert.

They are partnering with Nvidia, AMD, and Intel – the three biggest AI chip suppliers – on next-generation AI designs. So its customers will likely include all the big AI spenders like Meta, Amazon, Apple, and Tesla.

SMCI is forecasted to bust out an EPS growth rate of 31% moving forward.

The key risk ahead is that Dell and maybe even Hewlett Packard Enterprise might compete again with Supermicro’s capability in data centers and put its operating margins under pressure.

That could undermine the company’s profit outlook, especially if overall demand growth for data centers wavers.

The stock is expensive even to the point where short-term technical indicators have shown the stock to be overbought for the past 3 weeks.

In fact, the stock was sitting at $300 per share on January 18th and the parabolic trajectory has meant that the stock has more than doubled in the past few weeks.

Readers need to let this stock drop and any medium-sized pullback just be bought with two hands.

These types of premium AI stocks are hard to find optimal entry points which could mean a long wait time.

 

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-02-09 14:02:172024-02-09 14:56:08The New Hot A.I. Stock
Mad Hedge Fund Trader

February 9, 2024 - Quote of the Day

Tech Letter

“What's dangerous is not to evolve.” – Said Founder of Amazon Jeff Bezos

 

https://www.madhedgefundtrader.com/wp-content/uploads/2018/04/Jeff-Bezos-quote-photo-4-e1522806831697.jpg 272 300 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2024-02-09 14:00:532024-02-09 14:56:01February 9, 2024 - Quote of the Day
april@madhedgefundtrader.com

February 9, 2024

Jacque's Post

 

(SUMMARY OF JOHN’S WEBINAR FEBRUARY 7, 2024)

February 9, 2024

 

Hello everyone,

Title:  New All-Time Highs

 

Performance:

February +2.04%

2024 YTD =   -2.24%

51.27% - average annualized return

674.39% since inception

 

Positions:

(MSFT) 2/$330/$340 call spread

(AMZN) 2/$130/$135 call spread

(V) 2/ $240/$250 call spread

(PANW) 2/$260/$270 call spread

(CCJ) 2/$38/$41 call spread

Total Net Position 50.00%

 

The Method to My Madness

The one risk to my hyper-bullish scenario is that the economy doesn’t land at all and overheats forcing the FED to RAISE rates.

Focus remains on AI 5 with spectacular earnings announced last week.

All economic data is globally slowing, except for the U.S. with the only good economy in the world.

Saudi Arabia forced to cut oil production goals because of weak China demand.

Domestic plays have gone silent awaiting actual rate cuts.

Buy stocks and bonds but only after substantial dips.

Commodities and industrials are a second half play, we will keep rotating back and forth all year with tech.

 

The Trader’s Dilemma

The choice is now between 5 stocks that have gone up for 31/2 months, or a dozen interest rate sectors that may be dead money for four months.

Avoid the frustration trade, the one you should have done on October 26, look for the next one.

Wait for the ideal AI entry point, no matter how long it takes.

A big chunk of 2024 performance was pulled forward into 2023 and you made that money.

The sole exception is energy, which is driven by demand from the Chinese economy.

With markets at all-time highs 90-day T-bills are still yielding 5.43%.

 

The Global Economy – Beginning

Nonfarm Payroll Report comes in hot at 353,000.

The headline unemployment rate held at 3.7%.

The Fed turns dovish, with all members expecting the next move to be a rate cut.

Job openings hit a three-month high, while fewer Americans quit their jobs.

IMF upgrades Global Growth Forecast on the strength of the US by 0.2% to 3.1%

Chinese fiscal stimulus and a strong performance by large emerging market economies all contributed to the slightly brighter picture.

U.S. GDP rocketed by 2.5% in 2023, cementing its position as the strongest major economy in the world.  Q4 came in at a hot 3.3%

 

Stocks – New Highs!

SPY breaks to new high on strong consumer sentiment.

Big tech continues to dominate.

Market will continue to revalue all AI plays.

Biden to Announce Massive Chip Subsidies, to head off a coming shortage driven by AI.

Bull move could continue into February as investors are under-invested, or even short.

Regional Banks get another Scare, as New York Community Bank drops by half.

Domestic plays have gone back to sleep on rising rates.

The flip-flop continues between tech and domestics.

 

Bonds – Back to Life

U.S. Treasury borrowing to hit $760 billion in Q1, some $55 billion less than expected.

Q2 then drops to only $202 billion.

Bonds rallied on the good news.

U.S. Budget funded only until March 8.

Bonds could be the Big Trade of 2024.

Markets are discounting three cuts starting in May 2024 more likely.

Junk bond ETFs (JNK) and (HYG) are holding up extremely well with a 6.50% yield and 18-month high.

John is looking for an $18 - $28 point gain in 2024 with interest.

Buy (TLT) on the dip.

 

Foreign Currencies – US$ back in charge

Foreign currencies give up 2024 gains because of the return of higher U.S. interest rates.

A dollar rally could last a couple of months, so a new currency entry point is approaching.

However, eventual falling interest rates guarantee a falling dollar for 2024.

Bank of Japan eases grip on bond yields, ending its unlimited buying operation to keep interest rates down.

China markets dive, on news that the central bank was forced into the currency markets to support the yuan.

(FXA) to rally on coming bull markets in commodities.

Buy (FXY) on dips.

 

Energy & Commodities – Saudi Arabia Cuts

Saudi Arabia cuts oil production target – cratering prices and destroying the entire energy sector.

Lack of demand, especially from China, is the reason.

New U.S. output is fuel on the fire.

Production will be throttled back a million barrels to 12 million barrels a day as a long-term goal.

Freeport McMoran kills it, with an earnings upside blowout, taking the stock up 5%.

Political problems in Chile and Peru are an issue, which generates 40% of the world’s copper.

Electrification of the U.S. economy will continue to be a driving theme.

China in free fall is destroying the oil market, the world’s largest energy consumer. There is a “BUY” setting up here in energy when the global economy reaccelerates on a lower interest rates world.  Watch (XOM) and (OXY).

 

Precious Metals – Begging for a Breakout

Gold trending sideways awaiting decisive breakdown in interest rates.

Gold needs a return of falling interest rates to resume rally.

Miners are lagging gold performance but will play catch up.

Investors are picking up gold as a hedge for 2024 volatility.

Gold headed for $3000 by 2025 but backing off first from new all-time highs.

Silver is the better play with a higher beta.

Russia and China are also stockpiling gold to sidestep international sanctions.

 

Real Estate – Gearing up for Spring.

S&P Case Shiller Falls in November for the first time in nine months.

This was back when mortgage rates were peaking at 8.0%.

New Home Sales recover on a falling interest rate push, up 8.0% to 664,000.

Sales increased 4.4% on a year-on-year basis in December.

DR Horton misses in a rare sign of weakness in the new home building industry taking the shares down 10%.  This industry has a gale force demographic tailwind.

Tight supply and still-strong demand have kept pressure on home prices.

Do you live in Buffalo, New York? If so, you have the good fortune to occupy the hottest housing market in 2023.

 

Trade Sheet

Stocks – buy dips.

Bonds – buy dips.

Commodities – buy dips.

Currencies – sell dollar rallies, buy currencies.

Precious metals – buy dips.

Energy – buy dips.

Volatility – buy $12.

Real Estate – buy dips.

 

 

Cheers,

Jacquie

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-02-09 12:00:482024-02-09 10:44:24February 9, 2024
april@madhedgefundtrader.com

February 9, 2024

Diary, Newsletter, Summary

Global Market Comments
February 9, 2024
Fiat Lux

Featured Trade:

(FEBRUARY 7 BIWEEKLY STRATEGY WEBINAR Q&A),
(LLY), (FXI), (TSM), (BABA), (PLTR), (MSBHF), (SMCI), (JPM), (INDY), (INDA), (TSLA), (BYDDF), (NFLX), (META), (UNG)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-02-09 09:04:172024-02-09 09:57:06February 9, 2024
april@madhedgefundtrader.com

February 7 Biweekly Strategy Webinar Q&A

Diary, Newsletter

Below please find subscribers’ Q&A for the February 7 Mad Hedge Fund Trader Global Strategy Webinar, broadcast from Silicon Valley, CA.

Q: Have you ever flown an ME-262?

A: There's only nine of the original German jet fighters left from WWII in museums. One hangs from the ceiling in the Deutsches Museum in Munich (click here for the link), I have been there and seen it and it is truly a thing of beauty. You would have to be out of your mind to fly that plane, because the engines only had a 10 hour life. That's because during WWII, the Germans couldn't get titanium to make jet engine blades and used steel instead, and those fell apart almost as soon as they took off. So, of the 1,443 ME-262’s made there’s only nine left. The Allies were so terrified of this plane, which could outfly our own Mustangs by 100 miles per hour, that they burned every one they found. That’s also why there are no Japanese Zeros.

Q: Thoughts on Palantir (PLTR) long term?

A: I love it, it’s a great data and security play. Right now, markets are revaluing all data plays, whatever they are. But it is also overvalued having almost doubled in a week.

Q: What do you make of all these layoffs in Silicon Valley? What does this mean for tech stocks?

A: It means tech stocks go up. The tech stocks for a long time have practiced over-employment. They were growing so fast, they always kept a reserve of about 10% of extra staff so they could be put them to work immediately when the demand came. Now they are switching to a new business model: fire everybody unless you absolutely have to have them right now, and make everybody you have work twice as hard. That greatly increases the profitability of these companies, as we saw with META (META), which had its profits triple—and that seems to be the new Silicon Valley business model. If you're one of the few 100,000 that have been laid off in Silicon Valley, eventually the economy will grow back to where they can absorb you. That's how it's going to play out. In the meantime, go take a vacation somewhere, because you're not going to get any vacations once you get a new job.

Q: I have had shares of Alibaba (BABA) since 2020 and the stock has been in free fall since. Should I take the 80% loss or hold?

A: Well, number one, you need to learn about risk control. Number two, you need to learn about stop losses. I stop out when things go 10% against me; that's a good level. At 80%, you might as well keep the stock. You've already taken the loss and who knows, China may recover someday. It's not recovering now because no foreigners want to invest in China with all the political risk and invasion risk of Taiwan. After all, look at what happened to Russia when they invaded Ukraine—that didn't work out so well for them.

Q: On the Chinese economy (FXI), is the poorer performance due to the decision to move to a war economy? The move in the economic front was described in Xi's speech to the CCP in January of 2023.

A: The real reason, which no one is talking about except me, is the one child policy, which China practiced for 40 years. What it has meant is you now have 40 years of missing consumers that were never born. And there is no solution to that, at least no short-term solution. They're trying to get Chinese people to have more kids now, and you're seeing three and four child families for the first time in 40 years in China. But there is no short-term fix. When you mess with demographics, you mess with economic growth. We warned the Chinese this would happen at the time, and they ignored us. They said if they hadn't done the one child policy, the population of China today would be 1.8 billion instead of 1.2 billion. Well, they’re kind of damned no matter what they do so there was no good solution for them. Of course, threatening to invade your neighbors is never good for attracting foreign investment for sure. Nobody here wants to touch China with a 10-foot pole until there’s a new leader who is more pacifist.

Q: What do you think of Eli Lilly (LLY)?

A: I absolutely love it. If there's a never-ending bull market in fat Americans, which is will go on forever, they're one of two companies that have the cure at $1,000 a month. On the other hand, the stock has tripled in the last 18 months, so it’s kind of late in the game to get in.

Q: Are there any stocks that become an attractive short in the event of a Taiwan invasion, such as Taiwan Semiconductor (TSM)?

A: All stocks become attractive shorts in the event of another war in China. You don't want to be anywhere near stocks and the semis will have the greatest downside beta as they always do. You don't want to be anywhere near bonds either, because the Chinese still own about a trillion dollars’ worth of our bonds. Cash and T-bills suddenly looks great in the event of a third war on top of the two that we already have in Gaza and Ukraine.

Q: What do you think about the prospects of the Japanese stock market now?

A: I think the big move is done; it finally hit a new high after a 34-year wait. The next big move in Japan is when the Yen gets stronger, and that is bad for Japanese stocks, so I would be a little cautious here unless you have some great single name plays like Warren Buffett does with Mitsubishi Corp. (MSBHF). So that's my view on Japan—I'm not chasing it after being out for 34 years. Why return? The companies in the US are better anyway.

Q: What is the deal with Supermicro Computer (SMCI)? It went up 23 times in a year to $669 after not clear $30 for a decade.

A: The answer is artificial intelligence. It is basically creating immense demand for the entire chip ecosystem, including high end servers, which Supermicro makes. It also has the benefit of being a small company with a small float, hence the ballistic move. It was too small to show up on my radar. I’ll catch the next one. There are literally thousands of companies like (SMCI) in Silicon Valley.

Q: Will JP Morgan (JPM) bank shares keep rising, or will they fall when the Fed cuts rates?

A: (JPM) will keep rising because recovering economies create more loan demand, allow wider margins, and cause default rates to go down. It becomes a sort of best case scenario for banks, and JP Morgan is the best of the breed in the banking sector. It also benefits the most from the concentration of the US banking sector, which is on its way from 4,000 banks to 6 with help from the US government.

Q: Is India a good long-term play? Which of the two ETFs I recommend are the better ones?

A: Yes, India is a good long-term play. You buy both iShares India 50 (INDY) and the iShares MSCI India (INDA), which I helped create yonks ago. India is the new China, and the old China is going nowhere. So, yes, India definitely is a play, especially if the dollar starts to weaken.

Q: Do you expect to pull back in your market timing index?

A: Yes, probably this month. Have I ever seen it go sideways at the top for an extended period? No, I haven't. On the other hand, we’ve never had a new thing like artificial intelligence hit the market, nor have we seen five stocks dominate the entire market like we're seeing now. So, there are a lot of unprecedented factors in the market now which no one has ever seen before, therefore they don't know what to do. That is the difficulty.

Q: Does India have an in-country built EV, and what is their favorite EV in India?

A: No, but Tesla (TSLA) is talking about building a factory there. And I would have to say BYD Motors (BYDDF) because they have the world’s cheapest EV’s. There is essentially no car regulation in India except on imports. Car regulation and safety requirements is what keeps the BYDs out of the United States, and it's kept them out for the last 15 years. So that is the issue there.

Q: What do you think about META as a dividend play?

A: I think META will go higher, but like the rest of the AI 5, it is desperately in need of a pull back and a refresh to allow new traders to come in.

Q: Why does Netflix (NFLX) keep going up? I thought streaming was saturated—what gives?

A: Netflix won the streaming wars. They have the best content and the best business strategy; and they banned sharing of passwords, which hit my family big time since it seemed like the whole world was using my Netflix password. And no, I'm not going tell you what my password is. I’ve already paid for Griselda enough times. Seems there is a lot of demand for strong women in my family. Netflix they seem to be enjoying a near monopoly now on profits.

Q: Has the NASDAQ come too far too fast, and does it have more to run?

A: Well it does have more to run, but needs a pull back first. I'm thinking we'll get one this month, but I'm definitely not shorting it in the meantime.

Q: Have you ordered your Tesla (TSLA) Cybertruck?

A: I actually ordered it two years ago and it may be another two year wait; with my luck the order will come through when I'm in Europe and I'll miss it. Some of my friends have already gotten deliveries because they ordered on day one. They love it.

Q: What happened to United States Natural Gas (UNG)?

A: A super cold spell hit the Midwest, froze all the pipes, and nobody could deliver natural gas just when the power companies were screaming for more gas. That created the double in the price which you should have sold into! Usually, people don't need to be told to take a profit when something doubles in 2 weeks, but apparently there are some out there as I've been here getting emails from them. Further confusing matters further is that (UNG) did a 4:1 reverse split right at this time. They have to do this every few years or the 35% a year contango takes the price below $1.00 and shares can’t trade below $1.00 on the New York Stock Exchange.

To watch a replay of this webinar with all the charts, bells, whistles, and classic rock music, just log in to www.madhedgefundtrader.com , go to MY ACCOUNT, select your subscription (GLOBAL TRADING DISPATCH, TECHNOLOGY LETTER, or Jacquie's Post), then WEBINARS, and all the webinars from the last 12 years are there in all their glory.

Good Luck and Stay Healthy,

John Thomas
CEO & Publisher
The Diary of a Mad Hedge Fund Trader

 

 

 

 

 

 

https://www.madhedgefundtrader.com/wp-content/uploads/2018/09/John-drinking-wine-image-8-e1536960175180.jpg 318 350 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-02-09 09:02:132024-02-09 09:56:50February 7 Biweekly Strategy Webinar Q&A
Mad Hedge Fund Trader

February 9, 2024 - Quote of the Day

Diary, Newsletter, Quote of the Day

The earth has been playing in heavy traffic for 4 billion years now,
said Jeffrey Klugger, science editor of Time Magazine

https://www.madhedgefundtrader.com/wp-content/uploads/2013/02/Meteor.jpg 275 354 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2024-02-09 09:00:562024-02-09 09:59:28February 9, 2024 - Quote of the Day
april@madhedgefundtrader.com

February 8, 2024

Biotech Letter

Mad Hedge Biotech and Healthcare Letter
February 8, 2024
Fiat Lux

Featured Trade:

(THE WEIGHT IS OVER)

(REGN), (NVO), (LLY), (RHHBY)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-02-08 12:02:592024-02-08 12:06:12February 8, 2024
april@madhedgefundtrader.com

The Weight Is Over

Biotech Letter

Let's look into something that's been buzzing in the healthcare sector, and no, I'm not just talking about the latest diet fad. I’m talking about obesity treatments — specifically, those groundbreaking drugs that are reshaping the market and, quite literally, the patients using them.

Yes, I'm looking at you, GLP-1 agonists. These bad boys have been making waves for their significant role in weight loss, but let's face it, there's always room for a bit of an upgrade, right?

Despite all the cheers and positive vibes around GLP-1 agonists, a little detail has been creeping up that's somewhat less than ideal — muscle loss.

It turns out, up to a whopping 40% of the weight shed isn't just fat saying goodbye, but muscle bidding adieu as well. Not exactly the parting gift patients were hoping for, and frankly, it's stirring up some concerns that could ripple through public health in the not-so-distant future.

This is where Regeneron (REGN) comes in.

This biotechnology company isn’t new to the scene, but it’s taking a fresh angle on the whole ordeal. Their game plan? A dynamic duo approach, combining trevogrumab or garetosmab with the well-known semaglutide (hello, Wegovy), aiming to refine the weight loss journey for those embarking on it.

Regeneron’s goal is clear: let's keep the muscle, lose the fat, and change the narrative on obesity treatments.

Now, for a little context, the obesity treatment arena has been somewhat monopolized by Novo Nordisk (NVO) and Eli Lilly (LLY), with their respective champions, Wegovy and Zepbound, leading the charge.

But here's where Regeneron is looking to carve out its niche, not just in improving the now but in eyeing the future post-treatment landscape. The million-dollar question they're tackling: once the weight's off, how do you keep it from coming back without those weekly jab appointments?

To know the answer to that question, I suggest you mark your calendars for May 2024 because that's when the magic starts. It will commence Phase 2 of the study aiming to test Regeneron’s combo and hopefully offer better results to the weight loss game.

Ultimately, the company aims to preserve, or even boost, muscle mass. Imagine that, weight loss without the unwanted goodbye to your gains.

 

While it's worth noting that while Regeneron is making waves with its innovative approach, they're not alone in the quest for muscle preservation. Other players are also in the mix, each with their own strategies to combat the side effects of GLP-1 agonists.

Roche (RHHBY), for instance, has set its sights on combining their anti-myostatin antibody with incretin treatments, expanding the battlefield into new territories.

However, Regeneron’s plans don’t end in the weight loss world.

Earlier this month, Regeneron threw another curveball with the acquisition of 2seventy bio's cell therapy pipeline. This move isn't just about expanding their arsenal; it's about integrating and innovating in ways that could redefine cancer treatment as we know it.

By blending Regeneron's antibody expertise with 2seventy's cell therapy prowess, they're transforming into a potential oncology powerhouse.

Now, let's look at the numbers. Regeneron's market cap is flirting with the $100 billion mark, proof of their performance and potential. With revenues dancing around the $13 billion mark for 2023 and a price-to-sales ratio that's eye-catching, to say the least.

Yet, with every high, there's a looming challenge. The patent cliff for Eylea, their golden goose, is on the horizon, threatening to shake up the status quo.

But if there's one thing Regeneron has shown us, it's their knack for innovation. Given everything the company has embarked on over the past months, it’s safe to say that they’ve got this issue covered.

Does that mean it’s time to yell "screaming buy" from the rooftops? I usually keep such big words under lock and key, but Regeneron? They're onto something. They're not just surviving; they're plotting a course to new horizons without putting all their eggs in one basket. That strategy? It's more than just good—it's golden.

So while the cautious among us might wait for the market to blink first, there's something to be said for getting ahead of the curve. After all, in the world of pharma, timing is everything, and Regeneron seems to have its clock set just right.

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-02-08 12:00:522024-02-08 12:06:00The Weight Is Over
april@madhedgefundtrader.com

February 8, 2024

Diary, Newsletter, Summary

Global Market Comments
February 8, 2024
Fiat Lux

Featured Trade:

(A NOTE ON OPTIONS CALLED AWAY),
(MSFT), (PANW), (V), (GOOGL), (CCJ)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-02-08 09:04:052024-02-08 11:49:16February 8, 2024
april@madhedgefundtrader.com

A Note on Assigned Options, or Options Called Away

Diary, Newsletter

I was awoken this morning by calls from Concierge members asking what to do when their Visa (V) options were assigned or called away. The answer was very simple: fall down on your knees and thank your lucky stars. You have just made the maximum possible profit for your position instantly.

We have the good fortune to have five option call spreads that are deep in the money going into the February 16 option expiration. They include:

 

(MSFT) 2/$330-$340 call spread

(AMZN) 2/$130-$135 call spread

(V) 2/$240-$250 call spread

(PANW) 2/$260-$270 call spread

(CCJ) 2/$38-$41 call spread

 

In the run-up to every options expiration, which is the third Friday of every month, there is a possibility that any short options positions you have may get assigned or called away.

Most of you have short-option positions, although you may not realize it. For when you buy an in-the-money vertical option spread, it contains two elements: a long option and a short option.

The short options can get “assigned,” or “called away” at any time, as it is owned by a third party, the one you initially sold the put option to when you initiated the position.

You have to be careful here because the inexperienced can blow their newfound windfall if they take the wrong action, so here’s how to handle it correctly.

Let’s say you get an email from your broker telling you that your call options have been assigned away. I’ll use the example of the Visa (V) February 2024 $240-$250 in-the-money vertical BULL CALL debit spread.

For what the broker had done in effect allows you to get out of your call spread position at the maximum profit point 8 trading days before the February 16 expiration date. In other words, what you bought for $8.80 on January 10 is now $10.00!

All have to do is call your broker and instruct them to exercise your long position in your (V) February 2024 $240 calls to close out your short position in the (V) February 2024 $250 calls.

This is a perfectly hedged position, with both options having the same expiration date, and the same amount of contracts in the same stock, so there is no risk. The name, number of shares, and number of contracts are all identical, so you have no exposure at all.

Calls are a right to buy shares at a fixed price before a fixed date, and one option contract is exercisable into 100 shares.

To say it another way, you bought the (V) at $240 and sold it at $250, paid $8.80 for the right to do so, so your profit is $1.20 or ($1.20 X 100 shares X 12 contracts) = $1,440. Not bad for a 26-day defined limited-risk play.

Sounds like a good trade to me.

Weird stuff like this happens in the run-up to options expirations like we have coming.

A call owner may need to buy a long (V) position after the close, and exercising his long February $240 call is the only way to execute it.

Adequate shares may not be available in the market, or maybe a limit order didn’t get done by the market close.

There are thousands of algorithms out there that may arrive at some twisted logic that the calls need to be exercised.

Many require a rebalancing of hedges at the close every day which can be achieved through option exercises.

And yes, options even get exercised by accident. There are still a few humans left in this market to make mistakes.

And here’s another possible outcome in this process.

Your broker will call you to notify you of an option called away, and then give you the wrong advice on what to do about it. They’ll tell you to take delivery of your long stock and then most additional margin to cover the risk.

Either that, or you can just sell your shares on the following Monday and take on a ton of risk over the weekend. This generates oodles of commission for the brokers but impoverishes you.

There may not even be an evil motive behind the bad advice. Brokers are not investing a lot in training staff these days. It doesn’t pay. In fact, I think I’m the last one they did train 50 years ago.

Avarice could have been an explanation here but I think stupidity, poor training, and low wages are much more likely.

Brokers have so many legal ways to steal money that they don’t need to resort to the illegal kind.

This exercise process is now fully automated at most brokers but it never hurts to follow up with a phone call if you get an exercise notice. Mistakes do happen.

Some may also send you a link to a video of what to do about all this.

If any of you are the slightest bit worried or confused by all of this, come out of your position RIGHT NOW at a small profit! You should never be worried or confused about any position tying up YOUR money.

Professionals do these things all day long and exercises become second nature, just another cost of doing business.

If you do this long enough, eventually you get hit. I bet you don’t.

 

 

Calling All Options!

https://www.madhedgefundtrader.com/wp-content/uploads/2018/11/Call-Options.png 345 522 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-02-08 09:02:412024-02-08 11:49:03A Note on Assigned Options, or Options Called Away
Page 339 of 2206«‹337338339340341›»

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2026. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
Scroll to top